Transdermal nicotine system for smoking cessation

Abstract

LetterMarch 1, 1993Transdermal nicotine system for smoking cessationRowen K. Zetterman, MDRowen K. Zetterman, MDUniversity of Nebraska Medical Center, Omaha, Nebraska (R.K.Z.)Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/ACPJC-1993-118-2-062 SectionsAboutFull Text ToolsAdd to favoritesDownload CitationsTrack Citations ShareFacebookTwitterLinkedInRedditEmail To the EditorAn article published by the Transdermal Nicotine Study Group (Transdermal Nicotine System for Smoking Cessation) was abstracted and reviewed by ACP Journal Club (1). Because one of the authors is a friend, my attention was drawn to the comments of the reviewer. When this study was published, the authors carefully disclosed their financial relationships to the sponsoring pharmaceutical company. In his discussion the reviewer stated, ". . . 10 of the authors are identified as employees and stockholders . . . and 11 others have received honoraria and consultant fees from the maker . . ." He added, ...References1 Bronson DL. Commentary on "Transdermal Nicotine System for Smoking Cessation." ACP J Club. 1992 May-June:80 (Ann Intern Med. vol 116, suppl 3). Comment on: Transdermal Nicotine Study Group. Transdermal nicotine for smoking cessation. Six-month results from two multicenter controlled clinical trials. JAMA. 1991;266:3133-8. Google Scholar Author, Article, and Disclosure InformationAffiliations: University of Nebraska Medical Center, Omaha, Nebraska (R.K.Z.) PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails March 1, 1993Volume 118, Issue 2Page: 62KeywordsConflicts of interestDisclosureNicotine ePublished: 9 March 2020 Issue Published: March 1, 1993 Copyright & PermissionsCopyright © 1993 by American College of Physicians. All Rights Reserved.Loading ...